BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Masters MC, Krueger KM, Williams JL, Morrison L, Cohn SE. Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States. Expert Rev Clin Pharmacol 2019;12:1129-43. [PMID: 31774001 DOI: 10.1080/17512433.2019.1698946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Macdonell KK, Naar S. Self-Management Frameworks for Youth Living with Human Immunodeficiency Virus. Pediatric Clinics of North America 2022;69:759-77. [DOI: 10.1016/j.pcl.2022.04.007] [Reference Citation Analysis]
2 Saberi P, Campbell C, Sauceda JA, Ndukwe SO, Dube K. Perceptions of risks and benefits of participating in HIV cure-related research among diverse young adults living with HIV in the United States: qualitative research findings. AIDS Res Hum Retroviruses 2022. [PMID: 35579937 DOI: 10.1089/AID.2021.0192] [Reference Citation Analysis]
3 Raubinger S, Lee FJ, Pinto AN. HIV: the changing paradigm. Intern Med J 2022;52:542-9. [PMID: 35419962 DOI: 10.1111/imj.15739] [Reference Citation Analysis]
4 Figueroa JF, Katz IT, Hyle EP, Horneffer KE, Nambiar K, Phelan J, Orav EJ, Jha AK. The Association Of HIV With Health Care Spending And Use Among Medicare Beneficiaries. Health Aff (Millwood) 2022;41:581-8. [PMID: 35377765 DOI: 10.1377/hlthaff.2021.01793] [Reference Citation Analysis]
5 Kanazawa J, Gianella S, Concha-Garcia S, Taylor J, Kaytes A, Christensen C, Patel H, Ndukwe S, Rawlings SA, Hendrickx S, Little S, Brown B, Smith D, Dubé K. Ethical and practical considerations for HIV cure-related research at the end-of-life: a qualitative interview and focus group study in the United States. BMC Med Ethics 2022;23:2. [PMID: 35012544 DOI: 10.1186/s12910-022-00741-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Masters MC, Cohn SE. Two-drug HIV regimens: more data still needed. Lancet HIV 2021;8:e454-5. [PMID: 34358493 DOI: 10.1016/S2352-3018(21)00106-5] [Reference Citation Analysis]
7 Kanazawa JT, Saberi P, Sauceda JA, Dubé K. The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review. AIDS Res Hum Retroviruses 2021;37:75-88. [PMID: 33176429 DOI: 10.1089/AID.2020.0126] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
8 Nifant'ev I, Siniavin A, Karamov E, Kosarev M, Kovalchuk S, Turgiev A, Nametkin S, Bagrov V, Tavtorkin A, Ivchenko P. A New Approach to Developing Long-Acting Injectable Formulations of Anti-HIV Drugs: Poly(Ethylene Phosphoric Acid) Block Copolymers Increase the Efficiency of Tenofovir against HIV-1 in MT-4 Cells. Int J Mol Sci 2020;22:E340. [PMID: 33396968 DOI: 10.3390/ijms22010340] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Canetti D, Spagnuolo V. An evaluation of cabotegravir for HIV treatment and prevention. Expert Opin Pharmacother 2021;22:403-14. [PMID: 33112699 DOI: 10.1080/14656566.2020.1843635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Saberi P, Eskaf S, Sauceda J, Evans D, Dubé K. Perceptions of HIV Virologic Control Strategies Among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey. AIDS Res Hum Retroviruses 2020;36:606-15. [PMID: 32368934 DOI: 10.1089/AID.2020.0023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]